Back to Trades
Grant4
Jazz Pharmaceuticals plc
JAZZ
Total Value
$708.6K
Company Information
- Company Name
- Jazz Pharmaceuticals plc
- Ticker Symbol
- JAZZ
- CIK
- 0001232524
Insider Information
- Name
- Iannone Robert
- Role
- EVP, Global Head of R&D & CMO
- Location
- DUBLIN 4, L2
Officer
Filing Details
- Filing Date
- Jan 21, 2026
- Transaction Date
- Jan 16, 2026
- Accession Number
- 0001737329-26-000002
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jan 16, 2026 | Ordinary Shares | 11,699 | — | Grant/Award | — |
| Jan 16, 2026 | Ordinary Shares | 4,140 | $171.16 | Tax Withholding | $708.6K |
Footnotes
- (F1)Represents ordinary shares of the Issuer delivered pursuant to the terms of performance share awards made to the reporting person on March 3, 2023. The performance-based vesting requirements applicable to such awards were satisfied on January 16, 2026, which represents the date on which the level of performance attained was certified.
- (F2)The Reporting Person acquired 71 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 28, 2025.
- (F3)Shares withheld from the vesting and distribution of performance share awards to satisfy the reporting person's tax obligations.